Article
Caffeine and paraxanthine HPLC assay for CYP1A2 phenotype assessment using saliva and plasma.
Biomedical chromatography : BMC - 1 Oct 2010
Perera Vidya, Gross Annette S, McLachlan Andrew J
Abstract excerpt
Caffeine has been extensively used as a probe to measure CYP1A2 activity in humans with caffeine clearance or the paraxanthine (major metabolite of caffeine) to caffeine concentration ratio being regarded as the preferred metric. A simple reverse-phased C(18) HPLC assay using ethyl acetate liquid-liquid extraction was developed to quantitate caffeine and paraxanthine concentrations in saliva and plasma. The...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
